论文部分内容阅读
目的探讨氨氯地平阿托伐他汀钙片应用于高血压合并冠心病临床治疗中的可行性。方法选择2014年10月~2016年10月我院收治的高血压合并冠心病患者90例,分为对照组和观察组,各45例。对照组给予阿托伐他汀钙片实施治疗,观察组给予氨氯地平阿托伐他汀钙片实施治疗,观察两组患者的疗效。结果观察组总有效率为95.56%,对照组总有效率为68.89%,观察组总有效率明显比对照组高,差异有统计学意义(P<0.05)。结论氨氯地平阿托伐他汀钙片应用于高血压合并冠心病临床治疗中的可行性很大,有良好的疗效,值得推广使用。
Objective To investigate the feasibility of using amlodipine atorvastatin calcium in the clinical treatment of hypertension with coronary heart disease. Methods From October 2014 to October 2016, 90 patients with hypertension and coronary heart disease admitted to our hospital were divided into control group and observation group, with 45 cases in each group. The control group was treated with atorvastatin calcium, and the observation group was given amlodipine atorvastatin calcium tablets for treatment. The curative effect of the two groups was observed. Results The total effective rate was 95.56% in the observation group and 68.89% in the control group. The total effective rate in the observation group was significantly higher than that in the control group (P <0.05). Conclusion Amlodipine atorvastatin calcium tablets in the clinical treatment of hypertension with coronary heart disease is very feasible and has good curative effect, which is worth promoting.